News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 08, 2015, 16:27 ET

Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has suspended two planned clinical studies of the Company's CRF...

Jun 02, 2015, 08:00 ET

Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that Eric Benevich has joined the company as Chief Commercial Officer. "We are...

May 27, 2015, 15:54 ET

Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

May 12, 2015, 16:01 ET

Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will host an Analyst and Investor Day at the New York Palace Hotel in New...

May 08, 2015, 13:00 ET

Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

May 04, 2015, 16:01 ET

Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that Dr. Bill Aurora has joined the company as Vice President, Medical Affairs....

Apr 30, 2015, 13:00 ET

Neurocrine Biosciences to Present at the Deutsche Bank 40th Annual Health Care Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Apr 30, 2015, 07:00 ET

Neurocrine Biosciences Reports First Quarter 2015 Results

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2015. For the first quarter...

Apr 23, 2015, 13:00 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2015 results before the Nasdaq...

Mar 31, 2015, 22:00 ET

Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has entered into an exclusive collaboration and licensing agreement for the...

Mar 03, 2015, 13:00 ET

Neurocrine Biosciences to Present at the Barclays Global Healthcare Conference Live Audio Webcast Will be on March 10, 2015

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Feb 24, 2015, 13:00 ET

Neurocrine Biosciences to Present at Cowen and Company's 35th Annual Health Care Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Feb 20, 2015, 07:00 ET

Neurocrine Biosciences, Inc. Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the underwriters of its previously announced public offering have exercised in...

Feb 19, 2015, 07:00 ET

Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the pricing of its underwritten public offering of 6,944,000 shares of its common stock...

Feb 17, 2015, 16:08 ET

Neurocrine Biosciences, Inc. Announces Proposed Public Offering of $225 Million of Common Stock

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has commenced an underwritten public offering of shares of its common stock to...

Feb 09, 2015, 16:01 ET

Neurocrine Biosciences Reports Year-End 2014 Results and Provides Investor Update for 2015

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter and year ended December 31, 2014. For the...

Feb 04, 2015, 13:00 ET

Neurocrine Biosciences to Present at the 2015 Leerink Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be...

Feb 02, 2015, 13:00 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End 2014 Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its fourth quarter and year-end 2014 results after the...

Jan 20, 2015, 08:00 ET

Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical Trial Data in Classic Congenital Adrenal Hyperplasia at ENDO 2015

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the steering committee of ENDO 2015 has selected the abstract of their recently...

Jan 16, 2015, 14:30 ET

Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor...